ATM

Advertisement
Dec 27 2024HEALTH

The Mystery of Face Asymmetry: Decoding the PIK3CA Gene

Imagine growing up with one side of your face noticeably larger than the other— this is what congenital infiltrating lipomatosis does to young people. This rare disorder has baffled scientists for years, but recent discoveries are uncovering its secrets. The key seems to lie in the PIK3CA gene, whic

reading time less than a minute
Dec 26 2024HEALTH

Psoriasis Treatment: Age and BMI Matter

Did you know that age and body mass index (BMI) could play a significant role in how well a psoriasis treatment works? A recent study looked into a medication called deucravacitinib, a type of drug that blocks certain proteins in the body. This study wanted to find out what factors might make some p

reading time less than a minute
Dec 26 2024HEALTH

Thinking Clearly After Cancer: What Affects Young Adults' Brains?

Imagine you're a young adult who just went through cancer treatment. You might expect to feel physically better, but what about your brain? A recent study explored how cancer impacts young adults' thinking skills. They used both self-reports and tests. The study wanted to find out two things: first,

reading time less than a minute
Dec 26 2024HEALTH

Exploring the Promise of Vagus Nerve Stimulation in Stroke Therapy

Ever heard of the vagus nerve? It's a key player in our body's internal communication network. Lately, scientists have been buzzing about a technique called vagus nerve stimulation (VNS) as a possible game-changer in stroke treatment. This method involves zapping the vagus nerve with tiny electrical

reading time less than a minute
Dec 26 2024HEALTH

New Hope for Young Adults with Glioma: The Introduction of VoraSidenib

Isocitrate dehydrogenase (IDH)-mutant gliomas frequently strike young adults, causing severe brain tumors that disrupt their lives. These tumors are notorious for hindering cognitive abilities and, sadly, often lead to death. Current treatments, though life-prolonging, have serious side effects, dam

reading time less than a minute
Dec 26 2024HEALTH

The Race to Control Diabetes: What's the Best Way?

Imagine you're trying to choose the best medicine for diabetes. With so many options, it can be tough to know which one works best and has the fewest side effects. Researchers recently looked at three popular types of diabetes drugs: GLP-1RAs, DPP4is, and SGLT2is. They wanted to see who comes out on

reading time less than a minute
Dec 26 2024HEALTH

Unraveling the Real-World Success of Enfortumab Vedotin for Advanced Bladder Cancer

Let's dive into the effectiveness of Enfortumab Vedotin (EV) in tackling advanced urothelial carcinoma (a severe form of bladder cancer) in the real world. EV is a unique drug that combines two powerful actions: it targets the nectin-4 protein found in cancer cells and disrupts their structure by in

reading time less than a minute
Dec 26 2024HEALTH

The Uncertain Benefits of Ongoing Treatment for Stomach and Pancreas Neuroendocrine Tumors

Stomach and pancreas neuroendocrine tumors are quite the puzzle for doctors. They're not common and often go unnoticed until it's too late, making them difficult to tackle. When these tumors spread, doctors typically start with platinum-based chemotherapy. But here's where it gets confusing. After t

reading time less than a minute
Dec 26 2024HEALTH

Straightening Toes: A Comparison of Orthoses

You might not think much about your toes, but when they're not aligned properly, it can cause pain and discomfort. Hallux valgus is a condition where the big toe points outward and the toe joint sticks out. This study explored how two types of orthoses, or foot supports, can help with this condition

reading time less than a minute
Dec 25 2024HEALTH

Topiramate: A Fresh Look at Treating Kids' Fatty Liver Disease

Fatty liver disease in kids, often linked to obesity, is more common than you might think. While doctors usually suggest lifestyle changes first, these can be tough to stick to. That's where topiramate comes in. This medication is part of a weight loss combo drug for teens aged 12 and up, but docs s

reading time less than a minute